The explanation behind the development of hypertrophic cardiomyopathy in those patients is not yet determined, but it is thought to be due to high insulin concentrations that act through the insulin-like growth factor-I (IGF-1) receptor, which is also present in the heart [6, 7]. The gene discussed is IGF1; the disease is hypertrophic cardiomyopathy.